Abstract
Identification of active ligands using computational methods is a challenging task. For example, molecular docking, pharmacophore modeling, and three dimensional quantitative structure-activity relationship models (3D-QSAR) are widely used methods to identify novel small molecules. However, all these methods have, in addition to advantages, also significant pitfalls. The aim of this study was to compare some commonly used computational methods to estimate their ability to separate highly active PDE4B-inhibitors from less active and inactive ones. Here, 152 molecules with pIC50-range of 3.4-10.5, originating from six original studies were used. High correlation coefficients by using docking, docking with postprocessing with molecular mechanics-generalized Born-surface area -method (MMGBSA), pharmacophore modeling, and 3D-QSAR were obtained. These results are well in line with earlier studies done with similar methods, and suggest that computational methods could be successfully used to identify novel PDE4B-inhibitors, especially if using multiple methods together.
Keywords: Molecular docking, molecular mechanics-generalized born-surface area, pharmacophore modeling, phosphodiesterase, three-dimensional quantitative structure-activity relationship, virtual screening.
Current Drug Discovery Technologies
Title:Reliability of Virtual Screening Methods in Prediction of PDE4Binhibitor Activity
Volume: 12 Issue: 2
Author(s): Victoria Shubina, Sanna Niinivehmas and Olli T. Pentikainen
Affiliation:
Keywords: Molecular docking, molecular mechanics-generalized born-surface area, pharmacophore modeling, phosphodiesterase, three-dimensional quantitative structure-activity relationship, virtual screening.
Abstract: Identification of active ligands using computational methods is a challenging task. For example, molecular docking, pharmacophore modeling, and three dimensional quantitative structure-activity relationship models (3D-QSAR) are widely used methods to identify novel small molecules. However, all these methods have, in addition to advantages, also significant pitfalls. The aim of this study was to compare some commonly used computational methods to estimate their ability to separate highly active PDE4B-inhibitors from less active and inactive ones. Here, 152 molecules with pIC50-range of 3.4-10.5, originating from six original studies were used. High correlation coefficients by using docking, docking with postprocessing with molecular mechanics-generalized Born-surface area -method (MMGBSA), pharmacophore modeling, and 3D-QSAR were obtained. These results are well in line with earlier studies done with similar methods, and suggest that computational methods could be successfully used to identify novel PDE4B-inhibitors, especially if using multiple methods together.
Export Options
About this article
Cite this article as:
Shubina Victoria, Niinivehmas Sanna and Pentikainen T. Olli, Reliability of Virtual Screening Methods in Prediction of PDE4Binhibitor Activity, Current Drug Discovery Technologies 2015; 12 (2) . https://dx.doi.org/10.2174/1570163812666150702123018
DOI https://dx.doi.org/10.2174/1570163812666150702123018 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity
Current Medicinal Chemistry Chemokines in Rheumatic Diseases
Current Drug Targets Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Current Signal Transduction Therapy A Review on Polymeric Invasive and Non-Invasive Nanocarriers Assisted Transdermal Drug Delivery for Improved Penetration and Bioavailability
Drug Delivery Letters Thalidomide–A Notorious Sedative to a Wonder Anticancer Drug
Current Medicinal Chemistry Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism A Review on Rheumatoid Arthritis Interventions and Current Developments
Current Drug Targets Which Biomarker is Useful to Evaluate as a Treatment Outcome in Spondyloarthritis?
Current Rheumatology Reviews Vitamin D Analogs: Mechanism of Action and Therapeutic Applications
Current Medicinal Chemistry An Update of the Published Reports on Biologics Use for Psoriasis and the Reimbursement Status in Asia-Pacific Region
Current Rheumatology Reviews TNF as a Target of Inflammation in Rheumatoid Arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Retinoid Receptors in Inflammatory Responses: A Potential Target for Pharmacology
Current Drug Targets - Inflammation & Allergy Nanotechnology Allied to Nitric Oxide Release Materials for Dermatological Applications
Current Nanoscience Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry High Throughput Screening for Colorectal Cancer Specific Compounds
Combinatorial Chemistry & High Throughput Screening Biologic Therapy in Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report
Current Drug Safety Role of IL-17F in the Pathogenesis of Psoriasis
Current Immunology Reviews (Discontinued) Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal
Current Drug Safety